676 related articles for article (PubMed ID: 24627583)
21. Recent advances in the diagnosis of irritable bowel syndrome.
El-Salhy M
Expert Rev Gastroenterol Hepatol; 2015; 9(9):1161-74. PubMed ID: 26162959
[TBL] [Abstract][Full Text] [Related]
22. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones.
Meleine M; Matricon J
World J Gastroenterol; 2014 Jun; 20(22):6725-43. PubMed ID: 24944465
[TBL] [Abstract][Full Text] [Related]
23. Diet in irritable bowel syndrome.
El-Salhy M; Gundersen D
Nutr J; 2015 Apr; 14():36. PubMed ID: 25880820
[TBL] [Abstract][Full Text] [Related]
24. Irritable bowel syndrome: a gut microbiota-related disorder?
Bhattarai Y; Muniz Pedrogo DA; Kashyap PC
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G52-G62. PubMed ID: 27881403
[TBL] [Abstract][Full Text] [Related]
25. Irritable bowel syndrome: is the colonic mucosa to blame?
Hoffman JM
Neurogastroenterol Motil; 2012 Dec; 24(12):1051-3. PubMed ID: 23176660
[TBL] [Abstract][Full Text] [Related]
26. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype.
Belmonte L; Beutheu Youmba S; Bertiaux-Vandaële N; Antonietti M; Lecleire S; Zalar A; Gourcerol G; Leroi AM; Déchelotte P; Coëffier M; Ducrotté P
PLoS One; 2012; 7(8):e42777. PubMed ID: 23028414
[TBL] [Abstract][Full Text] [Related]
27. Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review).
Mazzawi T; El-Salhy M
Int J Mol Med; 2017 Oct; 40(4):943-952. PubMed ID: 28849091
[TBL] [Abstract][Full Text] [Related]
28. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.
Sinagra E; Morreale GC; Mohammadian G; Fusco G; Guarnotta V; Tomasello G; Cappello F; Rossi F; Amvrosiadis G; Raimondo D
World J Gastroenterol; 2017 Sep; 23(36):6593-6627. PubMed ID: 29085207
[TBL] [Abstract][Full Text] [Related]
29. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.
Öhman L; Törnblom H; Simrén M
Nat Rev Gastroenterol Hepatol; 2015 Jan; 12(1):36-49. PubMed ID: 25446728
[TBL] [Abstract][Full Text] [Related]
30. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
Mamieva Z; Poluektova E; Svistushkin V; Sobolev V; Shifrin O; Guarner F; Ivashkin V
World J Gastroenterol; 2022 Mar; 28(12):1204-1219. PubMed ID: 35431513
[TBL] [Abstract][Full Text] [Related]
31. Unraveling the ties between irritable bowel syndrome and intestinal microbiota.
Hong SN; Rhee PL
World J Gastroenterol; 2014 Mar; 20(10):2470-81. PubMed ID: 24627584
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating.
Ringel-Kulka T; Benson AK; Carroll IM; Kim J; Legge RM; Ringel Y
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G417-26. PubMed ID: 26702134
[TBL] [Abstract][Full Text] [Related]
33. Indication of immune activation in patients with perceived food hypersensitivity.
Lied GA
Dig Dis Sci; 2014 Feb; 59(2):259-66. PubMed ID: 24185686
[TBL] [Abstract][Full Text] [Related]
34. Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome.
Ivashkin V; Poluektov Y; Kogan E; Shifrin O; Sheptulin A; Kovaleva A; Kurbatova A; Krasnov G; Poluektova E
PLoS One; 2021; 16(6):e0252930. PubMed ID: 34115808
[TBL] [Abstract][Full Text] [Related]
35. Irritable bowel syndrome and food interaction.
Cuomo R; Andreozzi P; Zito FP; Passananti V; De Carlo G; Sarnelli G
World J Gastroenterol; 2014 Jul; 20(27):8837-45. PubMed ID: 25083057
[TBL] [Abstract][Full Text] [Related]
36. Irritable bowel syndrome: diagnosis and pathogenesis.
El-Salhy M
World J Gastroenterol; 2012 Oct; 18(37):5151-63. PubMed ID: 23066308
[TBL] [Abstract][Full Text] [Related]
37. The putative role of the intestinal microbiota in the irritable bowel syndrome.
Collins SM; Denou E; Verdu EF; Bercik P
Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
[TBL] [Abstract][Full Text] [Related]
38. Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.
Di Rosa C; Altomare A; Terrigno V; Carbone F; Tack J; Cicala M; Guarino MPL
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049488
[TBL] [Abstract][Full Text] [Related]
39. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?
Rajilić-Stojanović M; Jonkers DM; Salonen A; Hanevik K; Raes J; Jalanka J; de Vos WM; Manichanh C; Golic N; Enck P; Philippou E; Iraqi FA; Clarke G; Spiller RC; Penders J
Am J Gastroenterol; 2015 Feb; 110(2):278-87. PubMed ID: 25623659
[TBL] [Abstract][Full Text] [Related]
40. Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D.
Barbalho SM; Goulart RA; Araújo AC; Guiguer ÉL; Bechara MD
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):345-359. PubMed ID: 30791775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
